Robert M Dewitty

Array ( [id] => 4409646 [patent_doc_number] => 06265392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Low oxygen content compositions of 1.alpha., 25-dihydroxycholeclciferol' [patent_app_type] => 1 [patent_app_number] => 9/494674 [patent_app_country] => US [patent_app_date] => 2000-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 7369 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265392.pdf [firstpage_image] =>[orig_patent_app_number] => 494674 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1550831 [patent_doc_number] => 06399572 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-04 [patent_title] => 'Pharmaceutical preparation for the treatment of inflammatory processes' [patent_app_type] => B1 [patent_app_number] => 09/492790 [patent_app_country] => US [patent_app_date] => 2000-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1380 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/399/06399572.pdf [firstpage_image] =>[orig_patent_app_number] => 09492790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1500816 [patent_doc_number] => 06486144 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'Method of treatment of liver tumors and pharmaceutical compositions for use therein' [patent_app_type] => B1 [patent_app_number] => 09/445688 [patent_app_country] => US [patent_app_date] => 2000-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5207 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/486/06486144.pdf [firstpage_image] =>[orig_patent_app_number] => 09445688 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446878 [patent_doc_number] => 06369058 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Brain delivery of folic acid for the prevention of alzheimer\'s disease and stroke' [patent_app_type] => B1 [patent_app_number] => 09/482910 [patent_app_country] => US [patent_app_date] => 2000-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4629 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369058.pdf [firstpage_image] =>[orig_patent_app_number] => 09482910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1247566 [patent_doc_number] => 06673358 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-06 [patent_title] => 'Wet wipes containing a mono alkyl phosphate' [patent_app_type] => B1 [patent_app_number] => 09/464418 [patent_app_country] => US [patent_app_date] => 1999-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4434 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/673/06673358.pdf [firstpage_image] =>[orig_patent_app_number] => 09464418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435593 [patent_doc_number] => 06355235 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Topical application of antibodies for contraception and for prophylaxis against sexually transmitted diseases' [patent_app_type] => B1 [patent_app_number] => 09/447411 [patent_app_country] => US [patent_app_date] => 1999-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 8147 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355235.pdf [firstpage_image] =>[orig_patent_app_number] => 09447411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4082022 [patent_doc_number] => 06132774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Therapeutic combinations comprising a selective estrogen receptor modulator and parathyroid hormone' [patent_app_type] => 1 [patent_app_number] => 9/424010 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5190 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/132/06132774.pdf [firstpage_image] =>[orig_patent_app_number] => 424010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4421519 [patent_doc_number] => 06225294 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-01 [patent_title] => 'Method for inhibiting bone resorption' [patent_app_type] => 1 [patent_app_number] => 9/440577 [patent_app_country] => US [patent_app_date] => 1999-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9641 [patent_no_of_claims] => 94 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/225/06225294.pdf [firstpage_image] =>[orig_patent_app_number] => 440577 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1553846 [patent_doc_number] => 06348464 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-19 [patent_title] => 'Pyrrolecarbonylimino derivatives as naaladase inhibitors' [patent_app_type] => B1 [patent_app_number] => 09/438970 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 11354 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/348/06348464.pdf [firstpage_image] =>[orig_patent_app_number] => 09438970 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6356827 [patent_doc_number] => 20020058048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-16 [patent_title] => 'TOPICAL CAPSAICIN PREPARATION' [patent_app_type] => new [patent_app_number] => 09/438978 [patent_app_country] => US [patent_app_date] => 1999-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2851 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20020058048.pdf [firstpage_image] =>[orig_patent_app_number] => 09438978 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1507873 [patent_doc_number] => 06440967 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-08-27 [patent_title] => 'Combination of a GABAA alpha 5 inverse agonist and COX-2 inhibitor, NSAID, estrogen or vitamin E' [patent_app_type] => B1 [patent_app_number] => 09/438007 [patent_app_country] => US [patent_app_date] => 1999-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10598 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/440/06440967.pdf [firstpage_image] =>[orig_patent_app_number] => 09438007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4127265 [patent_doc_number] => 06127370 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Method for treating alzheimer\'s disease' [patent_app_type] => 1 [patent_app_number] => 9/435804 [patent_app_country] => US [patent_app_date] => 1999-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10180 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127370.pdf [firstpage_image] =>[orig_patent_app_number] => 435804 [rel_patent_id] =>[rel_patent_doc_number] =>)